Review abstract


Nature Chemical Biology 3, 541 - 548 (2007)
Published online: 20 August 2007 | doi:10.1038/nchembio.2007.24

Targeting virulence: a new paradigm for antimicrobial therapy

Anne E Clatworthy1, Emily Pierson1 & Deborah T Hung1


Clinically significant antibiotic resistance has evolved against virtually every antibiotic deployed. Yet the development of new classes of antibiotics has lagged far behind our growing need for such drugs. Rather than focusing on therapeutics that target in vitro viability, much like conventional antibiotics, an alternative approach is to target functions essential for infection, such as virulence factors required to cause host damage and disease. This approach has several potential advantages including expanding the repertoire of bacterial targets, preserving the host endogenous microbiome, and exerting less selective pressure, which may result in decreased resistance. We review new approaches to targeting virulence, discuss their advantages and disadvantages, and propose that in addition to targeting virulence, new antimicrobial development strategies should be expanded to include targeting bacterial gene functions that are essential for in vivo viability. We highlight both new advances in identifying these functions and prospects for antimicrobial discovery targeting this unexploited area.

Top
  1. Department of Molecular Biology and Center for Computational and Integrative Biology, Massachusetts General Hospital, 185 Cambridge St., Boston, Massachusetts 02114, USA; Department of Microbiology and Molecular Genetics, Harvard Medical School, 200 Longwood Ave., Boston, Massachusetts 02115, USA; and the Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA.

Correspondence to: Deborah T Hung1 e-mail: hung@molbio.mgh.harvard.edu



MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Filming bacteria

Nature Structural Biology News and Views (01 Nov 2003)

Medicine Virus deals anthrax a killer blow

Nature News and Views (22 Aug 2002)

See all 7 matches for News And Views

Extra navigation

Subscribe to Nature Chemical Biology

Subscribe

naturejobs

  • Protein Post Doc

    • The Novo Nordisk Foundation for Protein Research, University of Copenhagen / Novo Nordisk
    • Copenhagen, Denmark
  • Multiple Faculty Positions

    • University of Alabama at Birmingham Comprehensive Cancer Center
    • Birmingham, Alabama

natureproducts